Literature DB >> 11680518

Improved rat model for cerebral vasospasm studies.

T Meguro1, B R Clower, R Carpenter, A D Parent, J H Zhang.   

Abstract

While the rat has been used extensively in subarachnoid hemorrhage (SAH)-cerebral vasospasm studies, concerns exist whether this animal represents a usable model because its time course and pattern of cerebral vasospasm following SAH is not comparable to that observed in man. At present, our knowledge of the rat model is based almost exclusively on studies using a 'single hemorrhage' method. Since there is a positive correlation between severity of cerebral vasospasm, and volume of subarachnoid blood, an obvious question is whether the rat will show modifications in vascular responses when insulted by a second SAH. Here, an SAH was produced in rats using a 'double hemorrhage' method. Following SAH, cerebral arteries showed pathological alterations, significant decreases in luminal perimeter, and increases in arterial wall thickness, over a 7-day post-SAH period. The above vascular features are considered to be indicative of cerebral vasospasm and their presence over a 7-day post-SAH period represents a significant time extension when compared to a single hemorrhage. These modified vascular responses made the double hemorrhaged rat a much-improved animal model.

Entities:  

Mesh:

Year:  2001        PMID: 11680518     DOI: 10.1179/016164101101199144

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  12 in total

1.  Rosiglitazone attenuates cerebral vasospasm and provides neuroprotection in an experimental rat model of subarachnoid hemorrhage.

Authors:  Bo-Feng Lin; Chan-Yang Kuo; Li-Li Wen; Chun-Mei Chen; Ya-Feng Chang; Chih-Shung Wong; Chen-Hwan Cherng; Mei-Yu Chuang; Zhi-Fu Wu
Journal:  Neurocrit Care       Date:  2014-10       Impact factor: 3.210

2.  The effect of blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome in a rat model of subarachnoid hemorrhage.

Authors:  Matthew Boyko; Israel Melamed; Benjamin Fredrick Gruenbaum; Shaun Evan Gruenbaum; Sharon Ohayon; Akiva Leibowitz; Evgeny Brotfain; Yoram Shapira; Alexander Zlotnik
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

3.  Experimental subarachnoid hemorrhage: double cisterna magna injection rat model--assessment of delayed pathological effects of cerebral vasospasm.

Authors:  Erdem Güresir; Patrick Schuss; Valeri Borger; Hartmut Vatter
Journal:  Transl Stroke Res       Date:  2015-02-24       Impact factor: 6.829

Review 4.  The importance of early brain injury after subarachnoid hemorrhage.

Authors:  Fatima A Sehba; Jack Hou; Ryszard M Pluta; John H Zhang
Journal:  Prog Neurobiol       Date:  2012-03-10       Impact factor: 11.685

5.  Fundamental increase in pressure-dependent constriction of brain parenchymal arterioles from subarachnoid hemorrhage model rats due to membrane depolarization.

Authors:  Matthew A Nystoriak; Kevin P O'Connor; Swapnil K Sonkusare; Joseph E Brayden; Mark T Nelson; George C Wellman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-10       Impact factor: 4.733

6.  Dynamic CT perfusion imaging in subarachnoid hemorrhage-related vasospasm.

Authors:  A M Laslo; J D Eastwood; F-X Chen; T-Y Lee
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

7.  A minimally-invasive rat model of subarachnoid hemorrhage and delayed ischemic injury.

Authors:  Joshua R Dusick; Brandon C Evans; Azim Laiwalla; Scott Krahl; Nestor R Gonzalez
Journal:  Surg Neurol Int       Date:  2011-07-18

8.  Experimental subarachnoid hemorrhage in rats: comparison of two endovascular perforation techniques with respect to success rate, confounding pathologies and early hippocampal tissue lesion pattern.

Authors:  Anke Höllig; Agnieszka Weinandy; Kay Nolte; Hans Clusmann; Rolf Rossaint; Mark Coburn
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

9.  Valproic Acid Reduces Vasospasm through Modulation of Akt Phosphorylation and Attenuates Neuronal Apoptosis in Subarachnoid Hemorrhage Rats.

Authors:  Chieh-Hsin Wu; Yi-Cheng Tsai; Tai-Hsin Tsai; Keng-Liang Kuo; Yu-Feng Su; Chih-Hui Chang; Chih-Lung Lin
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

10.  Tat peptide-decorated gelatin-siloxane nanoparticles for delivery of CGRP transgene in treatment of cerebral vasospasm.

Authors:  Xin-Hua Tian; Zhi-Gang Wang; Han Meng; Yu-Hua Wang; Wei Feng; Feng Wei; Zhi-Chun Huang; Xiao-Ning Lin; Lei Ren
Journal:  Int J Nanomedicine       Date:  2013-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.